Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Carlsmed (CARL) Gross Profit (2024 - 2026)

Carlsmed filings provide 2 years of Gross Profit readings, the most recent being $11.6 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 65.26% to $11.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.4 million, a N/A change, with the full-year FY2025 number at $38.0 million, up 89.74% from a year prior.
  • Gross Profit hit $11.6 million in Q4 2025 for Carlsmed, up from $9.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $11.6 million in Q4 2025 to a low of $4.6 million in Q2 2024.